NANEXA — Nanexa AB Share News
0.000.00%
Last trade - 00:00- SEK676.32m
- SEK604.28m
- SEK36.15m
Brief: Nanexa Resolves On Fully Guaranteed Rights Issue Of About SEK 126.7 Million
Brief: Nanexa Filing Complaint Of Patent Infringement
Brief: Nanexa Granted Patent In China
Brief: Nanexa Q1 EBIT Loss Widens To SEK 6.6 Mln
Brief: Nanexa Launches Clinical Trial For NEX-18
Brief: Nanexa Announces Second Investment From Applied Ventures
Brief: Nanexa Q4 EBIT Loss Widens To SEK 7.8 Mln
Brief: Nanexa Signs Agreement With European Biotech Company For Evaluation Of PharmaShell
Brief: Nanexa Receives “Notice Of Allowance” In Canada
Brief: Nanexa Enters Into Cooperation Agreement With Applied Materials
Brief: Nanexa Receives Clinical Trial Approval For NEX-18
Brief: Nanexa In Talks With Applied Materials On Joint Development
Brief: Nanexa Gets Notice Of Allowance For Patent Application In Japan
Brief: Nanexa Gets Patent Approval In UK
Brief: Nanexa Q2 EBIT Loss Widnes To SEK 6.4 Mln
Brief: Nanexa Approved For Listing On Nasdaq First North Growth Market
Brief: Nanexa Approved For Listing On Nasdaq First North Growth Market
Brief: Nanexa Q1 EBIT Loss Widens To SEK 3.5 Mln
Brief: Nanexa: Animal Study Results Show Positive Properties Of PharmaShell